| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 14,794,800 | 14,930,400 | 14,833,900 | 12,961,400 | | Cost of Revenue | 13,755,000 | 13,914,500 | 13,889,800 | 11,991,400 | | | Gross Profit | 1,039,800 | 1,015,900 | 944,100 | 970,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 369,000 | 370,700 | 340,300 | 381,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 78,300 | 75,900 | 75,900 | 73,900 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 592,500 | 569,300 | 527,900 | 515,100 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,400 | 2,200 | 3,500 | 6,200 | | Earnings Before Interest And Taxes | 595,900 | 571,500 | 531,400 | 521,300 | | Interest Expense | 43,300 | 43,400 | 45,100 | 63,800 | | Income Before Tax | 552,600 | 528,100 | 486,300 | 457,500 | | Income Tax Expense | 217,100 | 215,900 | 195,300 | 183,200 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 335,500 | 312,200 | 291,000 | 274,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 335,500 | 312,200 | 291,000 | 274,300 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $335,500 | $312,200 | $291,000 | $274,300 |
|
0.49% Nasdaq 
Income Statement
